The recombinase-activating genes, RAG-1 and RAG-2, can be expressed by a subset of B cells within germinal centers, where they mediate secondary V(D)J rearrangements. This receptor revision mechanism could serve either receptor diversification or tolerance-induced functions. Alternatively, it might rescue those cells the receptors of which have been damaged by somatic mutation. Less is known about the occurrence of similar mechanisms in T cells. Here we show that mature T cells with defective TCR surface expression can express RAG genes and are capable of initiating secondary V(D)J rearrangements. The possibility that a cell rescue mechanism based on the generation of a novel Ag receptor might be active in peripheral T cells is envisaged.
T he recombinase-activating genes (RAG)
3 RAG-1 and RAG-2 (1) have long been considered to be expressed only in immature lymphocytes in bone marrow and thymus and readily down-regulated in mature IgD ϩ B cells and TCR ϩ T cells (2) (3) (4) . However, expression of RAG genes in germinal center (GC) B cells was demonstrated to mediate secondary V(D)J rearrangements (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Two recent papers suggested that lymphocytes with a pre-B cell phenotype accounted for RAG gene expression in the GC (15, 16) , thus indicating a persistent, rather than reinduced, RAG gene expression in some GC B cells. The significance of secondary rearrangements is debated: in early stages of the immune response receptor revision may represent a toleranceinduced mechanism to edit self-reactive B cells. In later stages, it can represent an additional means of somatic receptor diversification. In addition, it may rescue those B cells the receptors of which have been damaged by somatic mutations. We observed RAG expression in surface Ig Ϫ (sIg Ϫ ) human GC B cells (14) , and other authors previously demonstrated up-regulated RAG gene expression in sIg Ϫ variants of a human mature B cell line undergoing secondary rearrangements in vitro (17) . Furthermore, several groups have shown a potential link between the surface expression of Ag receptors and RAG expression, as the latter can be turned off by cross-linking the Ag receptors of mature B or T cells (12, 13, 18, 19) . This could suggest that a signal generated by the Ag receptor is required to inhibit or terminate RAG expression actively (4) .
Less is known on the occurrence of similar receptor revision events in T cells. Recently, RAG reexpression and DNA recombination in peripheral CD4 ϩ T cells have been described in a murine TCR ␤-chain transgenic model (20) . Interestingly, RAG reexpression was observed only in those cells that had downregulated transgenic V␤ expression (V␤5 Ϫ to V␤5 int ). On the hypothesis that RAG expression might be more likely in cells with defective TCR expression, as we observed in B cells, we asked whether peripheral T cells with decreased TCR surface expression were capable of expressing RAG genes and of undergoing secondary rearrangements.
Materials and Methods
Cell staining and cell sorting PBMC were obtained from two normal donors through Ficoll-Hypaque (Pharmacia Biotech, Upsala, Sweden) density gradient centrifugation. Indirect double staining using anti-human CD3 (OKT3, IgG2a) and anti-human CD4 (6D10, IgG1) mAbs were performed to sort the CD4 ϩ CD3 low cells. As second Abs, we used PE-labeled goat antimouse IgG2a and FITC-labeled goat anti-mouse IgG1 (Southern Bio- 
T cell cloning
The sorted cells were cloned at 0.3 cell/well in Terasaki plates in the presence of irradiated PBMC (0.5 ϫ 10 6 /ml) in complete RPMI 1640 supplemented with 5% human serum (EuroClone Ltd., U.K.), 1 g/ml PHA and 200 U/ml IL-2.
Northern blot analysis
10 g total RNA was electrophoresed through a 1.2% denaturing agarose gel, alkali blotted onto Hybond-N ϩ membrane (Amersham, Arlington Heights, IL) following the manufacturer's instructions and hybridized with C␤ and C␣ probes obtained by RT-PCR with the following primers: C␤ 5Ј, TGAGCCATCAGAAGCAGA; C␤ 3Ј, ATCTCATAGAGGATGGTGG; C␣ 5Ј, ATATCCAGAACCCTGACCCT; C␣ 3Ј, CTTTTCTCGACCA GCTTGAC.
Reverse transcription PCR and oligotyping
Total RNA was extracted with RNAzol B (Tel-test, Friendswood, TX) following the manufacturer's instructions. First-strand cDNA was synthesized using oligo(dT) and murine Moloney leukemia virus-RT (Promega, Madison, WI) in 20 l final volume, and 1 l was used in each PCR reaction. The primers were as follows: ␤-actin 5Ј, ACACTGTGCCCATC TACGAGGGG; ␤-actin 3Ј, ATGATGGAGTTGAAGGTAGTTTCGTG GAT; RAG-1 forward 5Ј, CCAAATTGCAGACATCTCAAC (corresponding to the 5Ј-untranslated sequence); RAG-1 reverse 5Ј, CAACATCT GCCTTCACATCGATCC (corresponding to the coding region); RAG-2 forward 5Ј, ATACCTGGTTTAGCGGCAAA (corresponding to the 5Ј-untranslated sequence); RAG-2 reverse 5Ј, CCAGCCTTTTTGTCCAAA GAA (corresponding to the coding region). The PCR profile was 2 min at 94°C, 30 cycles at 94°C for 15 s, 60°C for 20 s, 72°C for 40 s, followed by a 10-min extension. Nested PCR (20 cycles) was performed using 1 l of the first PCR and the following primers: RAG-1 internal 5Ј, CAGCCT GCTGAGCAAGGTAC; RAG-2 internal, 5Ј, ATGTCTCTGCAGATGG TAACAGT.
The PCR samples were electrophoresed and blotted. Filters were prehybridized in BLOTTO solution (6ϫ SSC, 1% milk, 5 mM EDTA, 0.1% SDS) at 42°C for 3 h and hybridized overnight at 42°C with the following internal oligonucleotides: RAG-1 5Ј, CAGTTCTGCCCCAGATGAAAT; RAG-2 5Ј, TCAGCCAGGCTTCTCACTGA.
Ligation-mediated PCR (LM-PCR)
The assay was performed as previously described (21) . The PCR samples were blotted, and filters were hybridized overnight at 37°C with the specific internal oligonucleotides. The primers were as follows: for the 5Ј D␤1: 5Ј-GCAGCTGCTCTGGTGGTC-3Ј (first PCR); 5Ј-TCTGGTGGTCTCT CCCAG-3Ј (nested); 5Ј-GGCTGTTTTTGTACAAAGC-3Ј (probe); for the 3Ј D␤1: 5Ј-CTGACATGTGATCAGGAGTGA-3Ј (first PCR); 5Ј-AA GACCTGTGACCCAGGA-3Ј (nested); 5Ј-GAAGAGGACTCTGGGA GT-3Ј (probe); for the 5Ј D␤2: 5Ј-CAGTCAGACTAACCTCTGCCA-3Ј (first PCR); 5Ј-GCTTCCTGCCGCTGCCCA-3Ј (nested); CTAGCAGGGAG GAAACATT-3Ј (probe); for the 3Ј D␤2: 5Ј-AAGACCACAGCTGGGAC CA-3Ј (first PCR); 5Ј-CCCACCTGGTAGCTGCATT-3Ј (nested); 5Ј-AT GCTTACTGCATCAGGGTT-3Ј (probe). Control reactions to determine the relative amounts of DNA were performed with primers to IL-5 gene: forward, 5Ј-GTGAAAGAGACCTTGGCACTG-3Ј; reverse, 5Ј-GGCAAAGTGTCAG TATGCCTG-3Ј.
Results

RAG gene expression in CD4 ϩ
CD3 low mature T cells
In the present study, we asked whether RAG expression could be found in mature T cells. No RAG-specific PCR products were observed when either PBMC or T cell lines from normal donors were analyzed (data not shown). On the hypothesis that RAG expression might be more likely in cells with absent or decreased expression of TCR from the cell surface, as we observed in B cells, we decided to isolate the TCR variant cells with a CD4 ϩ CD3 low phenotype that arise spontaneously in the periphery. These variant cells exist in detectable numbers (average, 2.4 ϫ 10 Ϫ4 ) among in vivo mature T cell populations and were reported to increase significantly with age (22, 23) .
Two-color fluorescence analysis of PBL from two normal donors stained with anti-CD3 and anti-CD4 Abs was performed with a cell sorter. The sorting window was set in the region for variant CD4 ϩ
CD3
low cells and ϳ2000 cells were sorted and cloned by limiting dilution. Of the 110 clones that could be established from these healthy donors, 34 were selected because they possessed a CD3 fluorescence intensity below the second log, at variance from normal T cell clones in which CD3 fluorescence is Ͼ10 2 (Fig. 1A) . All 34 clones turned out to be CD1a
Ϫ , -20 Ϫ , -56 Ϫ , and TCR␣␤ low (data not shown). Northern blot analysis indicated that most variant clones expressed full length TCR␣ and TCR␤ mRNA (Fig. 1B and data not shown) . In two clones, defective TCR␣ mRNA expression was found as compared with TCR␤ mRNA, which might explain the diminished surface TCR/CD3 complex expression (BC 10 and BC 17, Fig. 1B ). In the other clones, either small deletions or point mutations in the TCR mRNA or, alternatively, defects in CD3 chains expression could be the cause of the defective TCR/CD3 surface expression.
Using primers that span the single intron in the RAG genes, we asked whether these clones exhibited RAG gene expression. Although none of 15 normal, CD4 ϩ CD3 ϩ clones obtained from the same individuals showed any detectable RAG products, 11 variant clones (11 of 34, 32%) exhibited RAG-1 (clones BC 27, BC 79, LD202, and LD319), RAG-2 (clones BC 34, BC 88, BC 91, LD259, LD448,) or both RAG-1 and RAG-2 expression (clones BC 36 and BC 68) (Fig. 2 and data not shown) . The level of expression was low (10 3 -10 4 -fold less than CD4 Ϫ CD8 Ϫ thymocytes) but reproducible in independent experiments. On repeated in vitro stimulation with irradiated PBMC and PHA, 3 of the 11 RAG-expressing clones (BC 68, BC 79, and BC 88) became CD3 ϩ and lost RAG gene expression (data not shown).
Ongoing rearrangements of TCR genes in CD4
ϩ CD3 low T cells
To assess whether the RAG proteins expressed by the variant clones were capable of activating V(D)J recombination, we used the sensitive and highly specific LM-PCR assay (21) . We searched for rearrangement intermediates, i.e., double-stranded signal end breaks (SE breaks), in the TCR␤ locus using primers specific for the 5Ј and 3Ј sides of both D␤1 and D␤2. The presence of signal end intermediates is a stringent test of RAG activity, because recombination requires not only functional RAG-1 and RAG-2 proteins but also DNA accessibility. As expected, SE breaks associated with all four sites were detected in human thymic DNA (Fig.  3, lanes 1, 9, 10 clone BC 36 (Fig. 3, lane 13) ; after longer exposure, SE breaks associated with the 5Ј side of D␤2 were also detected in the same clone and SE breaks associated with the 3Ј side of D␤1 were detected in the RAG-1 ϩ /RAG-2 ϩ clone BC 68 (lane 5). No SE breaks could be detected in three clones which expressed only RAG-2 (Fig. 3, lanes 3, 12, and data not shown), nor in one RAG1 ϩ /RAG2 Ϫ clone (not shown). Taken together, these data indicate the presence of ongoing rearrangements at the TCR␤ locus in both clones exhibiting simultaneous expression of RAG genes. In the case of clone BC 36 LM-PCR indicated the occurrence of a complete secondary V(D)J rearrangement, whereas in the case of clone BC 68 a partial D-J rearrangement was evidenced.
Discussion
Overall, our data indicate that mature, CD4
ϩ CD3 low T lymphocytes can express RAG genes and are capable of initiating secondary V(D)J rearrangements.
Ligand-mediated positive selection is required for entrance and persistence of T cells in the peripheral pool (24, 25) . Thus, a lymphocyte that loses its Ag receptor becomes useless, and like anergic cells that have down-regulated their Ag receptors due to chronic exposure to a self Ag, must be eliminated. Similarly, it has been demonstrated that receptorless B cells obtained by artificial B cell receptor ablation, like anergic B cells, up-regulate Fas and die (26) . The RAG expression found in the CD3 low lymphocytes could suggest the interesting possibility that a mechanism of cellular rescue based on the generation of a novel Ag receptor through secondary rearrangements is active in these situations. Such a phenomenon would be analogous to the receptor-editing mechanism identified in bone marrow autoreactive cells (27) (28) (29) and in GC B cells (5) (6) (7) (8) (9) (10) (11) (12) (13) .
On a first analysis, two observations seemed to argue against a functional role of RAG genes in the CD4 ϩ CD3 low variant cells: their low level of expression and the very rare coexpression of RAG-1 and RAG-2 observed in the variant clones. Thus, it was essential to demonstrate the functionality of RAG proteins in mediating V(D)J recombination. On the one hand, the presence of signal end intermediates, a stringent test of RAG activity, clearly indicated the occurrence of ongoing rearrangements in both two RAG-1 ϩ /RAG-2 ϩ clones studied. On the other hand, it is difficult to explain why the majority of the clones seemed to express only one of the two RAG genes. The regulation of RAG-1 and RAG-2 expression is known to be very complex and involves both transcriptional and posttranscriptional controls (30, 31) . It is possible that expression of these genes in mature lymphocytes may be even more tightly regulated by the cell to avoid deleterious recombination errors, thus diminishing the probability of detecting both genes simultaneously.
In 3 of the 11 RAG-expressing clones, including one with SE breaks, we observed reappearance of a CD3 ϩ phenotype after repeated stimulation in vitro. Although the possibility that a successful secondary rearrangement occurred in these clones is appealing, we cannot yet formally prove that this was the case.
Recently, RAG reexpression and DNA recombination in peripheral CD4 ϩ T cells have been described in a murine TCR ␤-chain transgenic model (20) . In this model, tolerogen-mediated chronic peripheral selection against cells expressing the transgene led to RAG gene reexpression and resulted in surface expression of endogenous TCR ␤-chains. Consistent with our data, RAG reexpression was observed only in those cells with down-regulated transgenic V␤ expression (V␤5 Ϫ to V␤5 int ).
The possibility of secondary Ag receptor rearrangements can now be extended to human peripheral T cells. If the expression of RAG genes is a common feature of a subset of both B and T lymphocytes, it must confer significant benefit to immune function. However, it might also carry appreciable risks, including that of malignant transformation due to illegitimate recombination.
